ITUS (NASDAQ:ITUS) was downgraded by research analysts at ValuEngine from a “hold” rating to a “sell” rating in a research note issued on Thursday.

Shares of ITUS (ITUS) traded up $0.14 during mid-day trading on Thursday, hitting $2.73. The company had a trading volume of 100,641 shares, compared to its average volume of 525,807. ITUS has a fifty-two week low of $0.60 and a fifty-two week high of $6.10.

TRADEMARK VIOLATION NOTICE: This article was first published by American Banking News and is owned by of American Banking News. If you are reading this article on another website, it was stolen and reposted in violation of United States & international copyright legislation. The correct version of this article can be read at https://www.americanbankingnews.com/2017/12/09/valuengine-lowers-itus-itus-to-sell.html.

About ITUS

ITUS Corporation is engaged in developing a diagnostic platform called Cchek, for the early detection of tumor-based cancers. The Cchek cancer detection platform measures a patient’s immune response to a malignancy by detecting the presence, absence and quantity of certain immune cells that exist in and around a tumor and that enter the blood stream.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for ITUS Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ITUS Corp and related companies with MarketBeat.com's FREE daily email newsletter.